Medians of Continuous Variables by TEL-AML1
Variable . | TEL-AML1 . | |||
---|---|---|---|---|
Not Tested . | Negative . | Positive . | Overall . | |
N | 262 | 101 | 32 | 395 |
Age at initial diagnosis (mo)* | 60 | 74 | 53.5 | 63 |
Age at relapse diagnosis (mo) | 105 | 124 | 111.5 | 111 |
Duration of last remission (mo)† | 29 | 27 | 42.5 | 29 |
Log10 (peripheral blast cell count [1/μL] + 1) | 2.56 | 2.52 | 2.87 | 2.54 |
Log10 (WBC count [1/μL] + 1) | 3.77 | 3.79 | 3.75 | 3.77 |
Observation time (mo)‡ | 49 | 21 | 21.5 | 38 |
Variable . | TEL-AML1 . | |||
---|---|---|---|---|
Not Tested . | Negative . | Positive . | Overall . | |
N | 262 | 101 | 32 | 395 |
Age at initial diagnosis (mo)* | 60 | 74 | 53.5 | 63 |
Age at relapse diagnosis (mo) | 105 | 124 | 111.5 | 111 |
Duration of last remission (mo)† | 29 | 27 | 42.5 | 29 |
Log10 (peripheral blast cell count [1/μL] + 1) | 2.56 | 2.52 | 2.87 | 2.54 |
Log10 (WBC count [1/μL] + 1) | 3.77 | 3.79 | 3.75 | 3.77 |
Observation time (mo)‡ | 49 | 21 | 21.5 | 38 |
Significant difference between groups as assessed by Wilcoxon rank-sum test: *between TEL-AML1–positive and –negative, Z = −2.21336, P > ‖Z‖ = .0269; †betweenTEL-AML1– positive and –negative, Z = 4.35458, P > ‖Z‖ = .0001; ‡between tested and not tested, Z = −11.0831, P > ‖Z‖ = .0001.